Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s413217 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Zhongjie Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, 210023, People's Republic of China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
- College of Life Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
ORCID-Profile: Liefeng Zhang
Zitieren
APA
Wang, Z., Qin, Y., Wang, X., Zhang, T., Hu, Y., Wang, D., Zhang, L., & Zhu, Y. (2023). Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s413217
Vancouver
Wang Z, Qin Y, Wang X, Zhang T, Hu Y, Wang D, et al. Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s413217
BibTeX
@article{Wang2023,
author = {Wang, Zhongjie and Qin, Yanru and Wang, Xueyuan and Zhang, Tianyu and Hu, Yixue and Wang, Dongna and Zhang, Liefeng and Zhu, Yongqiang},
title = {Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s413217}
}
EUVIMED